283 related articles for article (PubMed ID: 35877038)
1. Cardiac Remodelling Following Cancer Therapy: A Review.
Panpan T; Yuchen D; Xianyong S; Meng L; Ruijuan H; Ranran D; Pengyan Z; Mingxi L; Rongrong X
Cardiovasc Toxicol; 2022 Sep; 22(9):771-786. PubMed ID: 35877038
[TBL] [Abstract][Full Text] [Related]
2. Hypertension and heart failure: a dysfunction of systole, diastole or both?
Yip GW; Fung JW; Tan YT; Sanderson JE
J Hum Hypertens; 2009 May; 23(5):295-306. PubMed ID: 19037230
[TBL] [Abstract][Full Text] [Related]
3. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
Poulsen SH
Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
[TBL] [Abstract][Full Text] [Related]
4. Complement component C3 and the TLR co-receptor CD14 are not involved in angiotensin II induced cardiac remodelling.
Shahini N; Schjalm C; Nilsson PH; Holt MF; Øgaard JDS; Lien E; Ahmed MS; Attramadal H; Aukrust P; Yndestad A; Mollnes TE; Louwe MC
Biochem Biophys Res Commun; 2020 Mar; 523(4):867-873. PubMed ID: 31955888
[TBL] [Abstract][Full Text] [Related]
5. [Diastolic cardiac failure: therapeutic modalities].
Millaire A
Arch Mal Coeur Vaiss; 1998 Nov; 91(11):1365-9. PubMed ID: 9864605
[TBL] [Abstract][Full Text] [Related]
6. Cellular, structural and functional cardiac remodelling following pressure overload and unloading.
Dadson K; Kovacevic V; Rengasamy P; Kim GH; Boo S; Li RK; George I; Schulze PC; Hinz B; Sweeney G
Int J Cardiol; 2016 Aug; 216():32-42. PubMed ID: 27140334
[TBL] [Abstract][Full Text] [Related]
7. Alterations in cardiovascular function in an experimental model of lung fibrosis and pulmonary hypertension.
Darwiche T; Collum SD; Bi W; Reynolds JO; Wilson C; Wareing N; Hernandez AM; Mertens TCJ; Zhou Z; Pandit LM; Karmouty-Quintana H
Exp Physiol; 2019 Apr; 104(4):568-579. PubMed ID: 30663834
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms contributing to cardiac remodelling.
Wu QQ; Xiao Y; Yuan Y; Ma ZG; Liao HH; Liu C; Zhu JX; Yang Z; Deng W; Tang QZ
Clin Sci (Lond); 2017 Sep; 131(18):2319-2345. PubMed ID: 28842527
[TBL] [Abstract][Full Text] [Related]
9. Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension.
Rol N; de Raaf MA; Sun XQ; Kuiper VP; da Silva Gonçalves Bos D; Happé C; Kurakula K; Dickhoff C; Thuillet R; Tu L; Guignabert C; Schalij I; Lodder K; Pan X; Herrmann FE; van Nieuw Amerongen GP; Koolwijk P; Vonk-Noordegraaf A; de Man FS; Wollin L; Goumans MJ; Szulcek R; Bogaard HJ
Cardiovasc Res; 2019 Feb; 115(2):432-439. PubMed ID: 30032282
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction.
Ainscough JF; Drinkhill MJ; Sedo A; Turner NA; Brooke DA; Balmforth AJ; Ball SG
Cardiovasc Res; 2009 Feb; 81(3):592-600. PubMed ID: 18703536
[TBL] [Abstract][Full Text] [Related]
11. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
[TBL] [Abstract][Full Text] [Related]
12. A state of reversible compensated ventricular dysfunction precedes pathological remodelling in response to cardiomyocyte-specific activity of angiotensin II type-1 receptor in mice.
Frentzou GA; Drinkhill MJ; Turner NA; Ball SG; Ainscough JF
Dis Model Mech; 2015 Aug; 8(8):783-94. PubMed ID: 26092119
[TBL] [Abstract][Full Text] [Related]
13. Chronic kidney disease and cardiac remodelling in patients with mild heart failure: results from the REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE) study.
Mathew J; Katz R; St John Sutton M; Dixit S; Gerstenfeld EP; Ghio S; Gold MR; Linde C; Shlipak MG; Deo R
Eur J Heart Fail; 2012 Dec; 14(12):1420-8. PubMed ID: 22956574
[TBL] [Abstract][Full Text] [Related]
14. Intercellular Adhesion Molecule 1 Regulates Left Ventricular Leukocyte Infiltration, Cardiac Remodeling, and Function in Pressure Overload-Induced Heart Failure.
Salvador AM; Nevers T; Velázquez F; Aronovitz M; Wang B; Abadía Molina A; Jaffe IZ; Karas RH; Blanton RM; Alcaide P
J Am Heart Assoc; 2016 Mar; 5(3):e003126. PubMed ID: 27068635
[TBL] [Abstract][Full Text] [Related]
15. Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension.
Rocchetti M; Sala L; Rizzetto R; Staszewsky LI; Alemanni M; Zambelli V; Russo I; Barile L; Cornaghi L; Altomare C; Ronchi C; Mostacciuolo G; Lucchetti J; Gobbi M; Latini R; Zaza A
Cardiovasc Res; 2014 Oct; 104(1):37-48. PubMed ID: 25139747
[TBL] [Abstract][Full Text] [Related]
16. Reverse remodelling in heart failure with cardiac resynchronisation therapy.
Sutton MS; Keane MG
Heart; 2007 Feb; 93(2):167-71. PubMed ID: 16644861
[TBL] [Abstract][Full Text] [Related]
17. Cardiac Injury Following Chemo/Radiation Therapy: An Updated Review on Mechanisms and Therapeutic Approaches.
Singh K; A Alameri A; Ali Hamza A; E Al-Gazally M; Temurovich Islomov S; Fadhel Obaid R; Alexis Ramírez-Coronel A; Abosaooda M; Yahyapour R; Najafi M
Curr Radiopharm; 2023 Jun; 16(3):185-203. PubMed ID: 36786135
[TBL] [Abstract][Full Text] [Related]
18. The disruption of invariant natural killer T cells exacerbates cardiac hypertrophy and failure caused by pressure overload in mice.
Takahashi M; Kinugawa S; Takada S; Kakutani N; Furihata T; Sobirin MA; Fukushima A; Obata Y; Saito A; Ishimori N; Iwabuchi K; Tsutsui H
Exp Physiol; 2020 Mar; 105(3):489-501. PubMed ID: 31957919
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous targeting of oxidative stress and fibrosis reverses cardiomyopathy-induced ventricular remodelling and dysfunction.
Wang C; Gaspari TA; Ferens D; Spizzo I; Kemp-Harper BK; Samuel CS
Br J Pharmacol; 2021 Jun; 178(12):2424-2442. PubMed ID: 33660265
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular reverse remodeling in dilated cardiomyopathy- maintained subclinical myocardial systolic and diastolic dysfunction.
Amorim S; Rodrigues J; Campelo M; Moura B; Martins E; Macedo F; Silva-Cardoso J; Maciel MJ
Int J Cardiovasc Imaging; 2017 May; 33(5):605-613. PubMed ID: 28013418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
